433 related articles for article (PubMed ID: 24292789)
21. Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt.
Juluri A; Peddikotla P; Repka MA; Murthy SN
J Pharm Sci; 2013 Feb; 102(2):500-7. PubMed ID: 23175436
[TBL] [Abstract][Full Text] [Related]
22. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
[TBL] [Abstract][Full Text] [Related]
23. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
24. Transdermal Delivery of Sumatriptan Succinate Using Iontophoresis and Dissolving Microneedles.
Ronnander JP; Simon L; Koch A
J Pharm Sci; 2019 Nov; 108(11):3649-3656. PubMed ID: 31374318
[TBL] [Abstract][Full Text] [Related]
25. In vitro transdermal iontophoretic delivery of leuprolide under constant current application.
Kochhar C; Imanidis G
J Control Release; 2004 Jul; 98(1):25-35. PubMed ID: 15245886
[TBL] [Abstract][Full Text] [Related]
26. In vitro iontophoretic delivery of nicorandil.
Ghosh B; Baser R; Patil UA; Dinesh BM
PDA J Pharm Sci Technol; 2010; 64(1):20-7. PubMed ID: 21502000
[TBL] [Abstract][Full Text] [Related]
27. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
Tratta E; Pescina S; Padula C; Santi P; Nicoli S
Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
[TBL] [Abstract][Full Text] [Related]
28. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565
[TBL] [Abstract][Full Text] [Related]
29. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
[TBL] [Abstract][Full Text] [Related]
30. Controlled transdermal iontophoresis for poly-pharmacotherapy: Simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo.
Cázares-Delgadillo J; Ganem-Rondero A; Merino V; Kalia YN
Eur J Pharm Sci; 2016 Mar; 85():31-8. PubMed ID: 26826281
[TBL] [Abstract][Full Text] [Related]
31. Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis.
Singh G; Ghosh B; Kaushalkumar D; Somsekhar V
AAPS PharmSciTech; 2008; 9(3):791-7. PubMed ID: 18592380
[TBL] [Abstract][Full Text] [Related]
32. Modulated iontophoretic delivery of small and large molecules through microchannels.
Kumar V; Banga AK
Int J Pharm; 2012 Sep; 434(1-2):106-14. PubMed ID: 22633929
[TBL] [Abstract][Full Text] [Related]
33. Iontophoresis - an approach for controlled drug delivery: a review.
Dixit N; Bali V; Baboota S; Ahuja A; Ali J
Curr Drug Deliv; 2007 Jan; 4(1):1-10. PubMed ID: 17269912
[TBL] [Abstract][Full Text] [Related]
34. Modulated delivery of donepezil using a combination of skin microporation and iontophoresis.
Kale M; Kipping T; Banga AK
Int J Pharm; 2020 Nov; 589():119853. PubMed ID: 32898633
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder.
Prasanthi D; Lakshmi PK
Int Braz J Urol; 2013; 39(1):63-75; discussion 76. PubMed ID: 23489517
[TBL] [Abstract][Full Text] [Related]
36. Transdermal absorption of memantin--effect of chemical enhancers, iontophoresis, and role of enhancer lipophilicity.
del Rio-Sancho S; Serna-Jiménez CE; Calatayud-Pascual MA; Balaguer-Fernández C; Femenía-Font A; Merino V; López-Castellano A
Eur J Pharm Biopharm; 2012 Sep; 82(1):164-70. PubMed ID: 22732268
[TBL] [Abstract][Full Text] [Related]
37. Transdermal iontophoresis of rotigotine: influence of concentration, temperature and current density in human skin in vitro.
Nugroho AK; Li G; Grossklaus A; Danhof M; Bouwstra JA
J Control Release; 2004 Apr; 96(1):159-67. PubMed ID: 15063038
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
Kalaria DR; Patel P; Patravale V; Kalia YN
Int J Pharm; 2012 Nov; 438(1-2):202-8. PubMed ID: 22954444
[TBL] [Abstract][Full Text] [Related]
39. Transdermal iontophoresis of insulin: III. Influence of electronic parameters.
Pillai O; Kumar N; Dey CS; Borkute ; Sivaprasad N; Panchagnula R
Methods Find Exp Clin Pharmacol; 2004; 26(6):399-408. PubMed ID: 15349135
[TBL] [Abstract][Full Text] [Related]
40. Passive and iontophoretic permeation of glipizide.
Jain A; Ghosh B; Rajgor N; Desai BG
Eur J Pharm Biopharm; 2008 Aug; 69(3):958-63. PubMed ID: 18291633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
